Valuation: Sartorius Stedim Biotech

Market Cap 22.07B 24.2B 20.4B 18.41B 34.68B 2,261B 36.04B 246B 97.41B 1,220B 90.77B 88.87B 3,854B P/E 2026 *
57.7x
P/E 2027 * 44.1x
Enterprise Value 24.06B 26.38B 22.25B 20.08B 37.81B 2,465B 39.3B 269B 106B 1,331B 98.98B 96.9B 4,202B EV / Sales 2026 *
7.68x
EV / Sales 2027 * 6.83x
Free-Float
28.47%
Yield 2026 *
0.36%
Yield 2027 * 0.44%
1 day+1.16%
Current month+1.52%
1 month+5.49%
3 months+25.65%
6 months+43.09%
Current year+8.00%
1 week 222.2
Extreme 222.2
228.8
1 month 208
Extreme 208
229.8
Current year 150
Extreme 150
229.8
1 year 150
Extreme 150
229.8
3 years 139.1
Extreme 139.1
281
5 years 139.1
Extreme 139.1
544
10 years 50.13
Extreme 50.13
551
Manager TitleAgeSince
Chief Executive Officer 51 28/03/2023
Chief Tech/Sci/R&D Officer 62 08/09/2011
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 65 07/04/2015
Director/Board Member 70 07/04/2015
Director/Board Member 69 14/09/2017
Date Insider Type Main position Quantity % Market Cap. Importance
17/12/25 SellCompany 750,000 0.7706%
16/02/24 Buy

Chief Executive Officer

1,716,739 1.8624%
02/03/22 SellCompany 200,442 0.2174%
Change 5-day change 1-year change 3-year change Capi.($)
+1.16%0.00%+21.58%+13.29% 24.03B
-0.22%-4.40%-19.63%+4.95% 181B
-1.56%-0.88%-0.08%+34.72% 125B
+0.19%-0.20%-11.51%+10.32% 121B
+1.12%-0.96%-41.94%+0.79% 90.52B
-0.64%-0.45%-3.69%+78.62% 66.9B
+0.31%+0.73%+12.35%-7.37% 58.68B
+1.19%-0.59%+4.22%+50.63% 54.38B
+0.77%-1.76%+3.79%+42.73% 48.46B
+0.84%+4.77%+3.97%-0.26% 35.4B
Average +0.32%-0.34%-3.09%+22.84% 81B
Weighted average by Cap. +0.03%-1.09%-8.94%+20.51%

Financials

2026 *2027 *
Net sales 3.13B 3.44B 2.9B 2.61B 4.92B 321B 5.12B 34.99B 13.83B 173B 12.89B 12.62B 547B 3.48B 3.82B 3.22B 2.91B 5.48B 357B 5.69B 38.91B 15.38B 193B 14.33B 14.03B 609B
Net income 384M 421M 355M 320M 603M 39.34B 627M 4.29B 1.69B 21.23B 1.58B 1.55B 67.05B 489M 537M 452M 408M 769M 50.14B 799M 5.46B 2.16B 27.06B 2.01B 1.97B 85.45B
Net Debt 1.99B 2.19B 1.84B 1.66B 3.13B 204B 3.26B 22.27B 8.8B 110B 8.2B 8.03B 348B 1.74B 1.91B 1.61B 1.45B 2.74B 179B 2.85B 19.47B 7.7B 96.42B 7.17B 7.02B 304B
Projected Income Statement - Annual - Sartorius Stedim Biotech
Logo Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key production sites are located in Germany, France and Puerto Rico.
Employees
10,483
Date Price Change Volume
18/11/26 €226.80 +1.16% 52,211
17/11/26 €224.20 -0.44% 67,748
16/11/26 €225.20 +0.90% 55,548
13/11/26 €223.20 +0.18% 56,546
12/11/26 €222.80 -1.76% 75,780
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Sartorius Stedim Biotech
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
226.80EUR
Average target price
250.00EUR
Spread / Average Target
+10.23%